Peter E. Vink

Pediatric Allergy and Immunology

2301 Renaissance Blvd
King Of Prussia, PA 19406

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 7 publications

Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients.

Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients.

Journal: The Journal of infection

Published: December 10, 2025

Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.

Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.

Journal: Vaccine

Published: June 07, 2022

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.

Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.

Journal: Human vaccines & immunotherapeutics

Published: June 30, 2021

Reply to Cheng et al and Nellore et al.

Reply to Cheng et al and Nellore et al.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 11, 2019

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 18, 2018

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

Journal: Cancer

Published: July 30, 2018

Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly.

Journal: Human vaccines & immunotherapeutics

Published: December 10, 2016

Showing 1-7 of 7

Last Updated: 09/26/2026